{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:32:24Z","timestamp":1787927544638,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpet.2026.104968","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:49:03Z","timestamp":1781711343000},"page":"104968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Apatinib inhibits gastric cancer progression by inducing ferroptosis through cysteine dioxygenase 1\/phosphoinositide 3-kinase\/Akt axis"],"prefix":"10.1016","volume":"393","author":[{"given":"Li-bin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7858-6043","authenticated-orcid":false,"given":"Wen-ji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpet.2026.104968_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jpet.2026.104968_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103841","article-title":"Characteristics of gastric cancer around the world","volume":"181","author":"L\u00f3pez","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104968_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5414\/CP204250","article-title":"Research progress in targeted therapies for gastric cancer","volume":"60","author":"Ye","year":"2022","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.jpet.2026.104968_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-018-0903-9","article-title":"Apatinib: a review in advanced gastric cancer and other advanced cancers","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jpet.2026.104968_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117106","article-title":"Therapeutic potentials of apatinib in cancer treatment: possible mechanisms and clinical relevance","volume":"241","author":"Fathi Maroufi","year":"2020","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104968_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-024-03262-z","article-title":"YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance","volume":"24","author":"Geng","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jpet.2026.104968_bib7","article-title":"Ferroptosis: biochemistry and biology in cancers","volume":"11","author":"Shi","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jpet.2026.104968_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2385406","article-title":"A novel ferroptosis-related gene risk signature for predicting prognosis and immunotherapy response in gastric cancer","volume":"2021","author":"Liu","year":"2021","journal-title":"Dis Markers"},{"issue":"3","key":"10.1016\/j.jpet.2026.104968_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.gendis.2021.12.023","article-title":"Cysteine dioxygenase type 1 (CDO1): its functional role in physiological and pathophysiological processes","volume":"10","author":"Chen","year":"2022","journal-title":"Genes Dis"},{"issue":"12","key":"10.1016\/j.jpet.2026.104968_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.6007","article-title":"Revealing the mechanism of Gualou-Xiebai against myocardial ischemia based on network pharmacology and energy metabolism strategies","volume":"38","author":"Jiang","year":"2024","journal-title":"Biomed Chromatogr"},{"issue":"7","key":"10.1016\/j.jpet.2026.104968_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S2468-1253(21)00109-6","article-title":"Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"6","author":"Qin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104968_bib12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jtho.2023.02.019","article-title":"Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab and apatinib in patients with resectable NSCLC: a phase 2 clinical trial","volume":"18","author":"Zhao","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104968_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13046-021-02069-4","article-title":"Apatinib triggers autophagic and apoptotic cell death via VEGFR2\/STAT3\/PD-L1 and ROS\/Nrf2\/p62 signaling in lung cancer","volume":"40","author":"Xie","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jpet.2026.104968_bib14","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.2147\/IJN.S477248","article-title":"A pH-responsive drug-delivery system based on apatinib-loaded metal-organic frameworks for ferroptosis-targeted synergistic anti-tumor therapy","volume":"19","author":"Yang","year":"2024","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1016\/j.jpet.2026.104968_bib15","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10120-021-01159-8","article-title":"Apatinib induced ferroptosis by lipid peroxidation in gastric cancer","volume":"24","author":"Zhao","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.jpet.2026.104968_bib16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2147\/CMAR.S274631","article-title":"Apatinib promotes ferroptosis in colorectal cancer cells by targeting ELOVL6\/ACSL4 signaling","volume":"13","author":"Tian","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jpet.2026.104968_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9925919","article-title":"Apatinib induces ferroptosis of glioma cells through modulation of the VEGFR2\/Nrf2 pathway","volume":"2022","author":"Xia","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"10.1016\/j.jpet.2026.104968_bib18","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1007\/s00432-023-04811-1","article-title":"Apatinib combined with olaparib induces ferroptosis via a p53-dependent manner in ovarian cancer","volume":"149","author":"Yue","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104968_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214872","article-title":"Cancer-specific promoter DNA methylation of cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer","volume":"14","author":"Harada","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jpet.2026.104968_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044951","article-title":"Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers","volume":"7","author":"Brait","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2026.104968_bib21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/biomedicines12040918","article-title":"The role of CDO1 in ferroptosis and apoptosis in cancer","volume":"12","author":"Chen","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpet.2026.104968_bib22","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1111\/cas.14181","article-title":"Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells","volume":"110","author":"Yu","year":"2019","journal-title":"Cancer Sci"},{"issue":"12","key":"10.1016\/j.jpet.2026.104968_bib23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.neo.2017.10.005","article-title":"Cysteine dioxygenase 1 mediates erastin-induced ferroptosis in human gastric cancer cells","volume":"19","author":"Hao","year":"2017","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.jpet.2026.104968_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001862","article-title":"The transcription factor HBP1 promotes ferroptosis in tumor cells by regulating the UHRF1-CDO1 axis","volume":"21","author":"Yang","year":"2023","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jpet.2026.104968_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.freeradbiomed.2024.04.222","article-title":"TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin\u2012proteasome system","volume":"219","author":"Zhang","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jpet.2026.104968_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1372330","article-title":"Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer","volume":"12","author":"Su","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jpet.2026.104968_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2284849","article-title":"Red ginseng polysaccharide promotes ferroptosis in gastric cancer cells by inhibiting PI3K\/Akt pathway through down-regulation of AQP3","volume":"25","author":"Wang","year":"2024","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104968_bib28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12964-025-02189-w","article-title":"CDO1 phosphorylation is required for IL-6-induced tumor cell proliferation through governing cysteine availability","volume":"23","author":"Li","year":"2025","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jpet.2026.104968_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10616-025-00798-4","article-title":"Mechanistic insights into Aloin-mediated regulation of STAT3\/SLC7A11 signaling in head and neck squamous cell carcinoma","volume":"77","author":"Wang","year":"2025","journal-title":"Cytotechnology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:11:25Z","timestamp":1787926285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022356526011675"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104968","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apatinib inhibits gastric cancer progression by inducing ferroptosis through cysteine dioxygenase 1\/phosphoinositide 3-kinase\/Akt axis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104968"}}